MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Biomed Realty Trust Company Profile (NYSE:BMR)

Consensus Ratings for Biomed Realty Trust (NYSE:BMR) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $22.94 (20.76% upside)

Analysts' Ratings History for Biomed Realty Trust (NYSE:BMR)
Show:
DateFirmActionRatingPrice TargetActions
7/30/2015Cowen and CompanyReiterated RatingOutperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Canaccord GenuityReiterated RatingHold$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2015Canaccord GenuityInitiated CoverageHold$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Jefferies GroupReiterated RatingHold$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Raymond JamesLower Price TargetOutperform$24.50 -> $23.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Robert W. BairdReiterated RatingOutperform$25.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Robert W. BairdReiterated RatingOutperform$25.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015MizuhoReiterated RatingNeutral$21.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015MLV & Co.Set Price TargetHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2015Jefferies GroupDowngradeBuy -> Hold$26.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015MLV & Co.Reiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015MizuhoReiterated RatingHold$23.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Stifel NicolausDowngradeBuy -> Hold$23.00 -> $23.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015MLV & Co.Reiterated RatingHold$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Cantor FitzgeraldReiterated RatingBuy$25.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Stifel NicolausReiterated RatingBuy$24.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014MizuhoBoost Price TargetBuy$23.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014MizuhoInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Stifel NicolausReiterated RatingBuy$23.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2014Jefferies GroupBoost Price Target$23.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2014MLV & Co.Initiated CoverageHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014Robert W. BairdBoost Price Target$22.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Stifel NicolausReiterated RatingBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Cowen and CompanyBoost Price Target$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/7/2014Raymond JamesLower Price Target$24.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2013KeyBancDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2013Cowen and CompanyUpgradeMarket Perform -> Outperform$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013Morgan StanleyUpgradeEqual Weight -> Overweight$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha